Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Synapse (New York, N.Y.)|May 25, 2012
Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([¹⁸F]AV-133) in a MPTP-lesioned PD mouse modelKo-Ting Chao, Hsin-Hsin Tsao, Yi-Hsin Weng, et al.
JAMA Neurology|April 24, 2014
Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomographyIng-Tsung Hsiao, Yi-Hsin Weng, Chia-Ju Hsieh, et al.
Molecular Imaging and Biology|December 12, 2003
Iodinated tracers for imaging amyloid plaques in the brainHang F Kung, Mei Ping Kung, Zhi Ping Zhuang, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 20, 2010
GMP-compliant automated synthesis of [(18)F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brainCheng-Hsiang Yao, Kun-Ju Lin, Chi-Chang Weng, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 30, 2013
In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PETShao-Cheng Lin, Kun-Ju Lin, Ing-Tsung Hsiao, et al.
Journal of Neurochemistry|October 24, 2007
Congo red and thioflavin-T analogs detect Abeta oligomersIzumi Maezawa, Hyun-Seok Hong, Ruiwu Liu, et al.
Nuclear Medicine and Biology|August 12, 2011
Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurementsKun-Ju Lin, Wey-Yil Lin, Chia-Ju Hsieh, et al.
Plos One|March 4, 2017
Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imagingChi-Chang Weng, Zi-An Chen, Ko-Ting Chao, et al.
Nuclear Medicine and Biology|May 8, 2010
Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot studyKun-Ju Lin, Wen-Chuin Hsu, Ing-Tsung Hsiao, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 25, 2017
Dual-phase 18F-florbetapir positron emission tomography in patients with primary progressive aphasia, Alzheimer's disease, and healthy controls: A preliminary studyHung-Chou Kuo, Ing-Tsung Hsiao, Chia-Ju Hsieh, et al.
Pageof 8